# Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab

> **NCT00820469** · PHASE4 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 20 (actual)

## Conditions studied

- Renal Transplant
- Autoimmune Diseases

## Interventions

- **DRUG:** Rituximab 375
- **DRUG:** rituximab 1000

## Key facts

- **NCT ID:** NCT00820469
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-11
- **Final completion:** 2010-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820469, "Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00820469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*